Use of metformin in polycystic ovary syndrome
- Ruchi Mathur,
- Carolyn J. Alexander,
- Jacqueline Yano,
- Bradley Trivax,
- Ricardo Azziz(corresponding author)
- Cedars-Sinai Medical Center,
- University of California at Los Angeles
Scholary Output:
Contribution to journal
Review article
Research
Peer-reviewSustainable Development Goals
- SDG 3 Good Health and Well
Abstract
<p>Women with polycystic ovary syndrome (PCOS) have a myriad of phenotypic and clinical features that may guide therapeutic options for metabolic protection and ovulation induction. The use of metformin may prove beneficial in a subset of the population of women with PCOS. Hyperinsulinemia, as demonstrated by elevated insulin levels on a 2-hour 75-g load glucose tolerance test, is an important parameter in deciding whether or not to initiate metformin therapy to women with PCOS with the hope of preventing or delaying the onset of type 2 diabetes mellitus (DM). Cardiovascular risk factors including markers of subclinical inflammation, and dyslipidemia may also be improved by metformin therapy. For ovulation induction, metformin is not as effective as clomiphene citrate as first-line therapy for women with PCOS. There are no clear data to suggest that metformin reduces pregnancy loss or improves pregnancy outcome in PCOS, and it is currently recommended that metformin be discontinued with the first positive pregnancy test result, unless there are other medical indications (eg, type 2 DM). This review addresses practical management guidelines for the uses of metformin in women with PCOS.</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Review article
Research
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 596-609 (14 pages)Journal (Volume, Issue Number)
American journal of obstetrics and gynecology (Volume 199, Issue 6)Publication milestones
- Published - 12/2008
Publication status
Published - 12/2008
ISSN
0002-9378Publication IDs
- Scopus: 57149142767
- PubMed: 19084097
Publication metrics
Metrics
SciVal
FWCI
4.25
SciVal
Author count
5
SciVal
citations
100
SciVal
Paper percentile
95
SciVal
Top percentile
5
Fractional count
1
Fractional count
0.20
Fractional count
4
Fractional count
0.80
Fractional count
1
Fractional count
1
PlumX, opens in new tab
Citation count
135
Captures
298
Mentions
3
